Artificial Intelligence in Genomics Market Analysis

Source Domain: www.openpr.com

The Artificial Intelligence in Genomics Market is expected to grow significantly, reaching $57.7 billion by 2035 with a CAGR of 50.8%.
The market is being driven by the need for innovative medications, enhanced genomic data interpretation, and the increasing use of AI in drug discovery and personalized medicine.
Major drivers for market growth include the high prevalence of chronic and genetic diseases, expanded research activities, and greater deployment in precision medicine.
Despite its promising growth, market adoption could face challenges due to limited AI expertise and a lack of understanding of AI applications.
North America holds the largest market share, followed by Europe, driven by robust R&D activities for precision medicine.
Key market players include AI Therapeutics, Ares Genetics, BenevolentAI, IBM, and NVIDIA among others, with significant collaborations and product launches.

You may have missed